Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
153.20
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
September 06, 2023
Pirola has about 30 mutations compared with previous omicron versions of the virus.
Via
Investor's Business Daily
Exposures
COVID-19
iPhone 15 May Face Hurdle In China, FTC Could Prosecute Amazon.com Over Antitrust Claims, United Airlines Planes Back In Air: Today's Top Stories
September 06, 2023
Wall Street Journal
Via
Benzinga
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
September 06, 2023
Moderna Inc's (NASDAQ: MRNA) clinical trial data from its research assay confirm that its updated COVID-19 vaccine generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86...
Via
Benzinga
Exposures
COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
Via
Benzinga
Peering Into Moderna's Recent Short Interest
September 05, 2023
Via
Benzinga
Moderna Unusual Options Activity For August 31
August 31, 2023
Via
Benzinga
Moderna Unusual Options Activity
August 25, 2023
Via
Benzinga
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...
Via
Benzinga
Exposures
COVID-19
A Bull Trap Or More Gas In The Tank? Prepare For The Upcoming Week With MandoTrading!
September 05, 2023
Last week's candle reached into a bearish imbalance, right at the 70% retracement of the current swing range and rejected. Bulls will need a close above that level for another upside push towards the...
Via
Benzinga
McDonald's, Moderna And 2 Other Stocks Insiders Are Selling
September 05, 2023
The Nasdaq 100 closed slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
September 05, 2023
Investors have worried about vaccine revenue in a post-pandemic world.
Via
The Motley Fool
Exposures
COVID-19
Check Out What Whales Are Doing With MRNA
August 22, 2023
Via
Benzinga
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
September 02, 2023
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.
Via
InvestorPlace
Surprise! This Potential AI Winner Isn't a Tech Stock.
September 02, 2023
I'll give you a hint: You've probably heard of this company's big product.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's Why the Next 4 Months May Be Critical for Pfizer
September 01, 2023
The pharmaceutical giant's stock has dropped by around 30% year to date.
Via
The Motley Fool
What's Going On With Moderna (MRNA) Stock?
August 31, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 2.4% to $113.80 Thursday afternoon. The stock has seen volatility in recent sessions amid rising COVID-19 cases in the U.S.
Via
Benzinga
Exposures
COVID-19
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.
Via
Benzinga
Exposures
COVID-19
Why Novavax Stock Was So Healthy on Monday
August 28, 2023
As the coronavirus threat rises, so too does the vaccine maker's value to investors.
Via
The Motley Fool
Exposures
COVID-19
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
Via
Benzinga
What's Going On With Moderna Stock Monday?
August 28, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading higher by roughly 2% to $114.12 Monday morning. The stock is rising amid rising COVID-19 cases in the U.S.
Via
Benzinga
Exposures
COVID-19
More Trouble Ahead For Bulls? Prepare For The Busy Upcoming Week With Mando Trading!
August 28, 2023
Jackson Hole Week comes to a close with a pretty ugly weekly candle. With DXY still strong, it's pretty hard for me to be bullish on the higher time frame right now. That weekly volume imbalance just...
Via
Benzinga
Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling
August 28, 2023
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
August 26, 2023
China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may...
Via
Talk Markets
Is Alexandria Real Estate Equities a Buy?
August 26, 2023
Great company, attractive valuation, lousy sector.
Via
The Motley Fool
Market Rally Attempt Suffers Big Reversal Amid Nvidia Earnings, Powell Speech: Weekly Review
August 25, 2023
A rally attempt gained momentum, until Thursday's ugly reversal.
Via
Investor's Business Daily
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.
Via
InvestorPlace
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Via
InvestorPlace
Exposures
COVID-19
Tuesday Talk: Monday Rebound
August 22, 2023
On Monday, the market rallied to rebound higher after a tough week of sideways and downward action. It remains to be seen if the rebound will be sustainable.
Via
Talk Markets
Nvidia, Zoom, Moderna, Baidu, Tesla: Why These Five Stocks Are Drawing Investors' Attention Today
August 21, 2023
Via
Benzinga
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.